HomeCompareJUPW vs MRK

JUPW vs MRK: Dividend Comparison 2026

JUPW yields 131.58% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JUPW wins by $13.05M in total portfolio value
10 years
JUPW
JUPW
● Live price
131.58%
Share price
$1.52
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13.11M
Annual income
$5,254,291.38
Full JUPW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JUPW vs MRK

📍 JUPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJUPWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JUPW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JUPW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JUPW
Annual income on $10K today (after 15% tax)
$11,184.21/yr
After 10yr DRIP, annual income (after tax)
$4,466,147.67/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JUPW beats the other by $4,457,819.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JUPW + MRK for your $10,000?

JUPW: 50%MRK: 50%
100% MRK50/50100% JUPW
Portfolio after 10yr
$6.58M
Annual income
$2,632,044.76/yr
Blended yield
39.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JUPW
No analyst data
Altman Z
-4.9
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JUPW buys
0
MRK buys
0
No recent congressional trades found for JUPW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJUPWMRK
Forward yield131.58%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$13.11M$56.8K
Annual income after 10y$5,254,291.38$9,798.13
Total dividends collected$12.01M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JUPW vs MRK ($10,000, DRIP)

YearJUPW PortfolioJUPW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$23,858$13,157.89$11,206$366.19+$12.7KJUPW
2$54,866$29,338.29$12,650$502.35+$42.2KJUPW
3$121,763$63,055.65$14,407$694.19+$107.4KJUPW
4$261,068$130,782.22$16,585$967.82+$244.5KJUPW
5$541,406$262,062.65$19,342$1,363.89+$522.1KJUPW
6$1,087,218$507,914.03$22,913$1,947.19+$1.06MJUPW
7$2,116,559$953,235.83$27,662$2,823.89+$2.09MJUPW
8$3,999,043$1,734,324.47$34,159$4,173.35+$3.96MJUPW
9$7,341,448$3,062,472.67$43,337$6,308.80+$7.30MJUPW
10$13,109,641$5,254,291.38$56,776$9,798.13+$13.05MJUPW

JUPW vs MRK: Complete Analysis 2026

JUPWStock

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Full JUPW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JUPW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JUPW vs SCHDJUPW vs JEPIJUPW vs OJUPW vs KOJUPW vs MAINJUPW vs JNJJUPW vs ABBVJUPW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.